Combining Early Heat Shock Protein Vaccination with Directed IL-2 Leads to Effective Anti-Tumor Immunity in Autologous Hematopoietic Cell Transplantation Recipients

被引：0
|
作者：
Newman, Robert G. [1 ]
Podack, Eckhard R. [1 ]
Levy, Robert B. [1 ]
机构：
[1] Sylvester Comprehens Canc Ctr, Sheila & David Fuente Grad Program Canc Biol, Miami, FL USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：456 / 456
页数：1
相关论文
共 18 条
  • [1] Combining early heat shock protein vaccination with directed IL-2 leads to effective and persistent antitumor immunity in recipients of experimental autologous hematopoietic cell transplantation.
    Newman, Robert G.
    Podack, Eckhard R.
    Levy, Robert B.
    CANCER RESEARCH, 2013, 73
  • [2] Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice
    Newman, Robert G.
    Dee, Michael J.
    Malek, Thomas R.
    Podack, Eckhard R.
    Levy, Robert B.
    BLOOD, 2014, 123 (19) : 3045 - 3055
  • [3] IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation
    Alvarez, Maite
    Dunai, Cordelia
    Khuat, Lam T.
    Aguilar, Ethan G.
    Barao, Isabel
    Murphy, William J.
    CANCERS, 2020, 12 (11) : 1 - 17
  • [4] Treg-targeted IL-2/anti-IL-2 complex controls graft-versus-host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation
    Thiolat, Allan
    Pilon, Caroline
    Caudana, Pamela
    Moatti, Audrey
    To, Nhu Hanh
    Sedlik, Christine
    Leclerc, Mathieu
    Maury, Sebastien
    Piaggio, Eliane
    Cohen, Jose L.
    HAEMATOLOGICA, 2024, 109 (01) : 129 - 142
  • [5] CLN-617 is a first-in-class fusion protein that retains IL-2 and IL-12 in the injected tumor and potently triggers systemic anti-tumor immunity
    Mehta, Naveen K.
    Rakhra, Kavya
    Meetze, Kristan
    Wittrup, K. Dane
    Michaelson, Jennifer S.
    Baeuerle, Patrick A.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Synergism between CpG ODN and IL-2 leads to massive CD8+ T cell responses against a self-antigen and epitope-specific anti-tumor immunity
    Kochenderfer, J
    Chien, C
    Gress, R
    BLOOD, 2004, 104 (11) : 884A - 884A
  • [7] Heat shock protein gp96 drives natural killer cell maturation and anti-tumor immunity by counteracting Trim28 to stabilize Eomes
    Xu, Yuxiu
    Li, Xin
    Cheng, Fang
    Zhao, Bao
    Fang, Min
    Li, Zihai
    Meng, Songdong
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [8] Heat shock protein gp96 drives natural killer cell maturation and anti-tumor immunity by counteracting Trim28 to stabilize Eomes
    Yuxiu Xu
    Xin Li
    Fang Cheng
    Bao Zhao
    Min Fang
    Zihai Li
    Songdong Meng
    Nature Communications, 15
  • [9] Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and May Lead to Eradication of Measureable Disease
    Rosenblatt, Jacalyn
    Avivi, Irit
    Binyamini, Noam
    Uhl, Lynne
    Somaiya, Poorvi
    Stroopinsky, Dina
    Palmer, Kristen Anna
    Coll, Maxwell Douglas
    Katz, Tami
    Bisharat, Lina
    Joyce, Robin
    Levine, James D.
    Arnason, Jon E.
    Luptakova, Katarina
    McMasters, Malgorzata
    Jain, Salvia
    Leiba, Merav
    Sato-Dilorenzo, Aya
    Logan, Emma
    Bryant, Mary Paty
    Held, Viki
    Richardson, Paul G.
    Laubach, Jacob P.
    Nagler, Arnon
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    Rowe, Jacob M.
    Kufe, Donald
    Avigan, David
    BLOOD, 2015, 126 (23)
  • [10] CLN-617 is an IL-2/IL-12 fusion protein with a collagen-anchoring domain that induces potent systemic anti-tumor immunity upon intra-tumoral administration
    Mehta, Naveen K.
    Li, Bochong
    Rakhra, Kavya
    Wittrup, K. Dane
    Baeuerle, Patrick A.
    Michaelson, Jennifer S.
    CANCER RESEARCH, 2022, 82 (12)
12